Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Validating Existing Scales for Identification of Acute Stroke in an Inpatient Setting.
Walking cadence as a measure of activity intensity and impact on functional capacity for prefrail and frail older adults.
Impact of a poor functional capacity on the clinical outcomes in patients with a pacemaker implantation -Results from the Japanese Heart Rhythm Society Registry.
Base-resolution sequencing of m6A in RNA
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022 12; 36(12):e22629.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Hemangioma, Cavernous, Central Nervous System
Human Umbilical Vein Endothelial Cells
Humans
Integrin beta1
Integrins
Mice
Microtubule-Associated Proteins
authors with profiles
Issam Awad
Robert Shenkar